LEADER 02249nam  2200481   450 
001 9910677942403321
005 20230629215114.0
010   $a1-119-59786-2
010   $a1-119-59789-7
010   $a1-119-59790-0
035   $a(CKB)4100000011961864
035   $a(MiAaPQ)EBC6644050
035   $a(Au-PeEL)EBL6644050
035   $a(OCoLC)1257666990
035   $a(EXLCZ)994100000011961864
100   $a20220203d2021      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aSarcopenia /$fedited by Alfonso J Cruz-Jentoft and John E. Morley
205   $aSecond edition.
210  1$aHoboken, New Jersey :$cWiley-Blackwell,$d[2021]
210  4$dİ2021
215   $a1 online resource (464 pages)
311   $a1-119-59787-0 
320   $aIncludes bibliographical references and index.
330   $a"Availability and standards on techniques to estimate muscle mass (or lean body mass) in epidemiological studies were becoming available. Based on these parameters, sarcopenia was operationally defined as a gradual loss of muscle mass. For instance, Baumgartner used a definition based on appendicular skeletal muscle mass estimated by DXA, corrected for height, and defined sarcopenia as being two standard deviations below sex specific means of healthy young persons (18-40 years) of a reference population 2. Longitudinal studies confirmed that a progressive reduction in muscle mass was present in both males and females 3. Muscle mass declines at approximately 1-2% per year after the age of 50 years. Sarcopenia, when defined as a severe muscle mass loss (two standard deviations below healthy young populations) is present in 5 to 13% of persons 60 to 70 years old and 11 to 50% of those over 80 years 4"--$cProvided by publisher.
606   $aMuscle strength
606   $aMuscle tone
615  0$aMuscle strength.
615  0$aMuscle tone.
676   $a612.6/7
702   $aCruz-Jentoft$b Alfonso J.
702   $aMorley$b John E.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910677942403321
996   $aSarcopenia$92585315
997   $aUNINA